Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures

Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity

(2015) L. J. Balcer et al.   NEUROLOGY

The Multiple Sclerosis Functional Composite: A clinically meaningful measure of disability

(2015) C. H. Polman et al.   NEUROLOGY

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

(2012) Jeffrey A Cohen et al.   LANCET NEUROLOGY

One Eye or Two: A Comparison of Binocular and Monocular Low-Contrast Acuity Testing in Multiple Sclerosis

(2011) Stacy L. Pineles et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Clinical consequences of MRI activity in treated multiple sclerosis

(2011) Diego Cadavid et al.   Multiple Sclerosis Journal

Clinical scales in progressive MS: predicting long-term disability

(2011) Libertje VAE Bosma et al.   Multiple Sclerosis Journal

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

(2011) Carolina Holmén et al.   Multiple Sclerosis Journal

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

(2011) DW Langdon et al.   Multiple Sclerosis Journal

Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis

(2010) Giuseppe Bomboi et al.   JOURNAL OF NEUROIMAGING

Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

(2010) LVAE Bosma et al.   Multiple Sclerosis Journal

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

(2010) SA Morrow et al.   Multiple Sclerosis Journal

Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study

(2010) Maria P Amato et al.   Multiple Sclerosis Journal

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis

(2009) James M. Stankiewicz et al.   JOURNAL OF NEUROIMAGING

Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity

(2009) E M Mowry et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS

(2009) L Strober et al.   Multiple Sclerosis Journal

Assessing disability progression with the Multiple Sclerosis Functional Composite

(2009) RA Rudick et al.   Multiple Sclerosis Journal

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test

(2009) AS Drake et al.   Multiple Sclerosis Journal

The FDA Critical Path Initiative and Its Influence on New Drug Development

(2008) Janet Woodcock et al.   Annual Review of Medicine

Oralmotor slowing in multiple sclerosis: Relationship to neuropsychological tasks requiring an oral response

(2008) PETER A. ARNETT et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire

(2008) RHB Benedict et al.   Multiple Sclerosis Journal

Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study

(2008) B Brochet et al.   Multiple Sclerosis Journal